Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11144289rdf:typepubmed:Citationlld:pubmed
pubmed-article:11144289lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:11144289lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:11144289lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:11144289lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:11144289lifeskim:mentionsumls-concept:C0238815lld:lifeskim
pubmed-article:11144289pubmed:issue5lld:pubmed
pubmed-article:11144289pubmed:dateCreated2000-12-28lld:pubmed
pubmed-article:11144289pubmed:abstractTextHLA-A, -B and -C genes were analysed in the population living in the metropolitan region of Curitiba, the main city of Parana State, southern Brazil, to provide data for studies and applications in HLA-related fields, and to contribute to the understanding of human microevolution. Heterozygosity is high (95-99%) for all three loci. Frequencies for most alleles and haplotypes of sub-Saharan African and of European ancestry presented a clear gradient between the White, Mulatto and Black subpopulations. Among Whites, the four most common haplotypes were A*01-Cw*07-B*0801, A*02-Cw*07-B*07, A*11-Cw*0401-B*35 and A*03-Cw*0401-B*35. Their frequencies ranged from 5.6% to 3.0%. In the Mulatto sub-population, six haplotypes presented very similar frequencies, close to 2.0-2.4%: A*02-Cw*03-B*15, A*02-Cw*0401-B*35, A*02-Cw*07-B*07, A*03-Cw*0401-B*35, A*30-Cw*17-B*4201, A*68-Cw*03-B*15. Haplotype A*30-Cw*17-B*4201 was found to be very common (6.6%) in the Black sub-population. Admixture estimate revealed the relative contributions of Europeans, sub-Saharan Africans and Amerindians to this populations which were, respectively, 94%, 3% and 3% for the White sub-population, 57%, 39% and 4% for the Mulatto sub-population, and 25%, 74% and 1% for the Black sub-population.lld:pubmed
pubmed-article:11144289pubmed:languageenglld:pubmed
pubmed-article:11144289pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11144289pubmed:citationSubsetIMlld:pubmed
pubmed-article:11144289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11144289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11144289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11144289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11144289pubmed:statusMEDLINElld:pubmed
pubmed-article:11144289pubmed:monthNovlld:pubmed
pubmed-article:11144289pubmed:issn0001-2815lld:pubmed
pubmed-article:11144289pubmed:authorpubmed-author:Petzl-ErlerM...lld:pubmed
pubmed-article:11144289pubmed:authorpubmed-author:CulpiLLlld:pubmed
pubmed-article:11144289pubmed:authorpubmed-author:Braun-PradoKKlld:pubmed
pubmed-article:11144289pubmed:authorpubmed-author:Vieira...lld:pubmed
pubmed-article:11144289pubmed:authorpubmed-author:Farah...lld:pubmed
pubmed-article:11144289pubmed:issnTypePrintlld:pubmed
pubmed-article:11144289pubmed:volume56lld:pubmed
pubmed-article:11144289pubmed:ownerNLMlld:pubmed
pubmed-article:11144289pubmed:authorsCompleteYlld:pubmed
pubmed-article:11144289pubmed:pagination417-27lld:pubmed
pubmed-article:11144289pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:meshHeadingpubmed-meshheading:11144289...lld:pubmed
pubmed-article:11144289pubmed:year2000lld:pubmed
pubmed-article:11144289pubmed:articleTitleHLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population.lld:pubmed
pubmed-article:11144289pubmed:affiliationLaboratory of Human Molecular Genetics, Federal University of Paraná, Curitiba, Brazil.lld:pubmed
pubmed-article:11144289pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11144289pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3105entrezgene:pubmedpubmed-article:11144289lld:entrezgene
entrez-gene:3106entrezgene:pubmedpubmed-article:11144289lld:entrezgene
entrez-gene:3107entrezgene:pubmedpubmed-article:11144289lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11144289lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11144289lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11144289lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11144289lld:pubmed